These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 11793064)
1. Implanted vascular access devices (ports) in children: complications and their prevention. Babu R; Spicer RD Pediatr Surg Int; 2002 Jan; 18(1):50-3. PubMed ID: 11793064 [TBL] [Abstract][Full Text] [Related]
2. [Experience with implanted ports for venous access between 2005 and 2012]. Kovács E; Deme E; Bencsik G Orv Hetil; 2014 Jun; 155(25):986-92. PubMed ID: 24936574 [TBL] [Abstract][Full Text] [Related]
3. Implantable venous access devices in children with severe hemophilia: a tertiary pediatric institutional experience. Bedoya MA; Raffini L; Durand R; Acord MR; Srinivasan A; Krishnamurthy G; Vatsky S; Escobar F; Cahill AM Pediatr Radiol; 2020 Jul; 50(8):1148-1155. PubMed ID: 32390060 [TBL] [Abstract][Full Text] [Related]
4. Experience with 100 consecutive central venous access arm ports placed by interventional radiologists. Hills JR; Cardella JF; Cardella K; Waybill PN J Vasc Interv Radiol; 1997; 8(6):983-9. PubMed ID: 9399467 [TBL] [Abstract][Full Text] [Related]
5. Long-term, totally implantable central venous access ports connected to a Groshong catheter for chemotherapy of solid tumours: experience from 178 cases using a single type of device. Biffi R; Corrado F; de Braud F; de Lucia F; Scarpa D; Testori A; Orsi F; Bellomi M; Mauri S; Aapro M; Andreoni B Eur J Cancer; 1997 Jul; 33(8):1190-4. PubMed ID: 9301441 [TBL] [Abstract][Full Text] [Related]
6. Radiological placement of chest ports in pediatric oncology patients. Cil BE Eur Radiol; 2004 Nov; 14(11):2015-9. PubMed ID: 15249980 [TBL] [Abstract][Full Text] [Related]
7. Complications in connection with venous port systems: prevention and therapy. Rauthe G; Altmann C Eur J Surg Oncol; 1998 Jun; 24(3):192-9. PubMed ID: 9630859 [TBL] [Abstract][Full Text] [Related]
8. Complications associated with an implantable vascular access device. Dillon PA; Foglia RP J Pediatr Surg; 2006 Sep; 41(9):1582-7. PubMed ID: 16952595 [TBL] [Abstract][Full Text] [Related]
10. Totally implantable central venous access ports for long-term chemotherapy. A prospective study analyzing complications and costs of 333 devices with a minimum follow-up of 180 days. Biffi R; de Braud F; Orsi F; Pozzi S; Mauri S; Goldhirsch A; Nolè F; Andreoni B Ann Oncol; 1998 Jul; 9(7):767-73. PubMed ID: 9739444 [TBL] [Abstract][Full Text] [Related]
11. Radiologic placement of a low profile implantable venous access port in a pediatric population. Nosher JL; Bodner LJ; Ettinger LJ; Siegel RL; Gribbin C; Asch J; Drachtman RA Cardiovasc Intervent Radiol; 2001; 24(6):395-9. PubMed ID: 11907746 [TBL] [Abstract][Full Text] [Related]
12. A comparison of infections and complications in central venous catheters in adults with solid tumours. Coady K; Ali M; Sidloff D; Kenningham RR; Ahmed S J Vasc Access; 2015; 16(1):38-41. PubMed ID: 25198809 [TBL] [Abstract][Full Text] [Related]
13. Complications associated with totally implantable access ports in children less than 1 year of age. Ross AB; Rouanet E; Murphy AJ; Weldon CB; Weil BR J Pediatr Surg; 2022 Oct; 57(10):463-468. PubMed ID: 34991865 [TBL] [Abstract][Full Text] [Related]
14. Clinical impact of peripherally inserted central catheters vs implanted port catheters in patients with cancer: an open-label, randomised, two-centre trial. Taxbro K; Hammarskjöld F; Thelin B; Lewin F; Hagman H; Hanberger H; Berg S Br J Anaesth; 2019 Jun; 122(6):734-741. PubMed ID: 31005243 [TBL] [Abstract][Full Text] [Related]
15. [Application of long term subcutaneously implanted access into the central veins system of "PORT" type in the Clinic of Pediatry, Pediatric Hematology and Oncology in Zabrze--15 year own observations]. Bucki B; Tomaszewska R; Bubała H; Sońta-Jakimczyk D; Karpe J; Stoksik P Wiad Lek; 2009; 62(2):93-8. PubMed ID: 20141056 [TBL] [Abstract][Full Text] [Related]
16. Risk profile of subcutaneous port placement in small children. Overman RE; Casar Berazaluce AM; Van Arendonk K; Wagner ML; Kartal T; Witte A; Rymeski B; Speck KE J Pediatr Surg; 2021 Jan; 56(1):183-186. PubMed ID: 33131779 [TBL] [Abstract][Full Text] [Related]
17. Impact of decreased heparin dose for flush-lock of implanted venous access ports in pediatric oncology patients. Rosenbluth G; Tsang L; Vittinghoff E; Wilson S; Wilson-Ganz J; Auerbach A Pediatr Blood Cancer; 2014 May; 61(5):855-8. PubMed ID: 24464964 [TBL] [Abstract][Full Text] [Related]
18. Infectious morbidity associated with long-term use of venous access devices in patients with cancer. Groeger JS; Lucas AB; Thaler HT; Friedlander-Klar H; Brown AE; Kiehn TE; Armstrong D Ann Intern Med; 1993 Dec; 119(12):1168-74. PubMed ID: 8239247 [TBL] [Abstract][Full Text] [Related]
19. Implanted vascular access device options: a focused review on safety and outcomes. Blanco-Guzman MO Transfusion; 2018 Feb; 58 Suppl 1():558-568. PubMed ID: 29443407 [TBL] [Abstract][Full Text] [Related]
20. Comparison of totally implanted reservoirs with external catheters as venous access devices in pediatric oncologic patients. Ross MN; Haase GM; Poole MA; Burrington JD; Odom LF Surg Gynecol Obstet; 1988 Aug; 167(2):141-4. PubMed ID: 3400032 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]